Want to join the conversation?
$NFLX 2Q15 PR: Diluted EPS for the quarter amounted to $0.06 after adjustment for NFLX 7-for-1 stock split (EPS would have been $0.42 using pre-split share count). NFLX remain committed to running around break-even globally on a net income basis through 2016, and to then deliver material global profits in 2017 and beyond.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.